Nasdaq Eigr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq eigr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Eigr Today - Breaking & Trending Today

Head-To-Head Survey: Eiger BioPharmaceuticals (NASDAQ:EIGR) and XOMA (NASDAQ:XOMAP)

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) and XOMA (NASDAQ:XOMAP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Insider and Institutional Ownership 62.5% of Eiger BioPharmaceuticals shares […] ....

United States , Palo Alto , Asia Pacific , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Get Free Report , Given Eiger Biopharmaceutical , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Stock Comparison , Stock Analysis ,

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

Investment analysts at StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Eiger BioPharmaceuticals has a 52-week low of $1.10 and a 52-week high of $43.35. The stock has […] ....

United States , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Get Free Report , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Initiated Coverage , Stocknews Com ,

Eiger BioPharmaceuticals (NASDAQ:EIGR) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance Shares of EIGR stock opened at $1.30 on Friday. The firm’s 50 day moving average price is $5.72 and its […] ....

United States , Charles Schwab Investment Management Inc , Virtu Financial , Metlife Investment Management , Eiger Biopharmaceuticals Inc , Dimensional Fund Advisors , Eiger Biopharmaceuticals , Free Report , Life Investment Management , Fund Advisors , Schwab Investment Management , Street Corp , Get Free Report , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Down 0.3 % EIGR stock opened at $5.80 on Monday. The firm has a 50 day moving average of $6.89 […] ....

United States , Eiger Biopharmaceuticals Company Profile , Morgan Stanley , Vanguard Group Inc , Ameriprise Financial Inc , Eiger Biopharmaceuticals Inc , Barclays Plc , Eiger Biopharmaceuticals , Free Report , Biopharmaceuticals Stock Down , Street Corp , Get Free Report , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a report published on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance Shares of EIGR stock opened at $6.11 on Friday. The company has a debt-to-equity ratio of 2.64, a quick ratio of […] ....

United States , Morgan Stanley , Eiger Biopharmaceuticals Inc , Ameriprise Financial Inc , Barclays Plc , Vanguard Group Inc , Eiger Biopharmaceuticals , Free Report , Get Free Report , Street Corp , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Initiated Coverage , Stocknews Com ,